StonvexLoading…
StonvexStonvexStonvexCore line items from CLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $117.56M | $424.83M | $312.51M | $206.38M |
Operating Income | $-2.90M | $-159.86M | $-149.17M | $-135.53M |
Net Income | $-12.41M | $-222.02M | $-179.03M | $-155.21M |
EPS (Diluted) | $-0.06 | $-1.01 | $-0.81 | $-0.70 |
Total Assets | $1.04B | $1.06B | $1.13B | $1.12B |
Total Liabilities | $473.17M | $491.65M | $534.05M | $519.00M |
Cash & Equivalents | $55.48M | $155.58M | $180.84M | $132.09M |
Free Cash Flow OCF − CapEx | $-15.26M | $59.85M | $53.35M | $46.88M |
Shares Outstanding | 220.22M | 219.33M | 219.29M | 219.19M |